ArticleFrontiers in clinical diabetes and healthcare2022

A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study.

Suzanne Meiring et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.